102 related articles for article (PubMed ID: 2654677)
1. [Increase in Parkinson symptoms caused by calcium antagonists].
Hefner R; Fischer PA
Nervenarzt; 1989 Mar; 60(3):187-8. PubMed ID: 2654677
[No Abstract] [Full Text] [Related]
2. [Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].
Martí Massó JF
Neurologia; 1986; 1(2):55-7. PubMed ID: 3079110
[No Abstract] [Full Text] [Related]
3. [Comment on the contribution by R. Hefner and P.-A. Fischer. Increase in Parkinson symptoms in treatment with calcium antagonists].
Philipps GR
Nervenarzt; 1989 Sep; 60(9):587. PubMed ID: 2812165
[No Abstract] [Full Text] [Related]
4. Flunarizine-induced parkinsonism: clinical report.
Moretti A; Lucantoni C
Ital J Neurol Sci; 1988 Jun; 9(3):295-7. PubMed ID: 3403223
[TBL] [Abstract][Full Text] [Related]
5. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
6. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
Frenken CW; Nuijten ST
Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
[TBL] [Abstract][Full Text] [Related]
7. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists in the prevention of motion sickness.
Lee JA; Watson LA; Boothby G
Aviat Space Environ Med; 1986 Jan; 57(1):45-8. PubMed ID: 3510617
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers and cardiovascular complications in hypertensive diabetics.
Hardy KJ; Flynn CA
J Fam Pract; 1998 Jun; 46(6):454-5. PubMed ID: 9638103
[No Abstract] [Full Text] [Related]
10. Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics.
Schoenberger JA
Angiology; 1988 Jan; 39(1 Pt 2):87-93. PubMed ID: 3277494
[TBL] [Abstract][Full Text] [Related]
11. Parkinson-like side effects during prolonged treatment with flunarizine.
Di Rosa AE; Morgante L; Meduri M; Musolino R; Leggiadro N; Coraci M; Crisafulli A; Di Perri R
Funct Neurol; 1987; 2(1):47-50. PubMed ID: 3315874
[TBL] [Abstract][Full Text] [Related]
12. [Epilepsy: fewer attacks with flunarizine].
Fortschr Med Suppl; 1985; 8():13-5. PubMed ID: 2867019
[No Abstract] [Full Text] [Related]
13. [Brain organic psychosyndrome. More satisfaction with flunarizine].
Fortschr Med Suppl; 1985; 8():17-8. PubMed ID: 2867021
[No Abstract] [Full Text] [Related]
14. [Calcium antagonists: safe or unsafe?].
Rosendaal FR; Psaty BM; Furberg CD
Ned Tijdschr Geneeskd; 1996 Apr; 140(17):916-8. PubMed ID: 8676969
[No Abstract] [Full Text] [Related]
15. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
Frishman WH; Charlap S
Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
[TBL] [Abstract][Full Text] [Related]
16. [Parkinson syndrome from diltiazem].
Remblier C; Kassir A; Richard D; Pérault MC; Guibert S
Therapie; 2001; 56(1):57-9. PubMed ID: 11322019
[No Abstract] [Full Text] [Related]
17. [Managing vertebrobasilar insufficiency effectively. Flunarizine normalizes the incidence of nystagmus].
Fortschr Med Suppl; 1986; 1():11-3. PubMed ID: 2868978
[No Abstract] [Full Text] [Related]
18. [Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies].
Hofferberth B
Fortschr Med; 1984 Jul; 102(27-28):725-8. PubMed ID: 6383990
[TBL] [Abstract][Full Text] [Related]
19. Extrapyramidal symptoms and flunarizine.
Di Rosa A
Funct Neurol; 1988; 3(2):237-8. PubMed ID: 3402820
[No Abstract] [Full Text] [Related]
20. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
